Sort
85,873 grants matching “alzheimers”
Natural Language Processing and Automated Speech Recognition to Identify Older Adults with Cognitive Impairment
$815,237Alex D. Federman · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AG
Magnetic Resonance Spectroscopy Core Facility
$815,221Jun Shen · National Institute Of Mental Health · Z01 · FY2008 · MH
Sex-based contributors to vulnerability to Alzheimer's disease: a multimodal imaging study
$815,215Carolyn Anne Fredericks · Yale University · R01 · FY2025 · AG
Core A: Administrative Core
$815,178Margaret A Pericak-Vance · University Of Miami School Of Medicine · U19 · FY2022 · AG
Alzheimer's Disease and Related Dementia Care within the Medicare Program
$815,120John Hsu · Massachusetts General Hospital · R01 · FY2022 · AG
Alzheimer's Disease and Related Dementia Care within the Medicare Program
$815,091John Hsu · Massachusetts General Hospital · R01 · FY2019 · AG
Identification and Characterization of Novel AD Genes
$815,077Massachusetts General Hospital · R37 · FY2003 · MH
Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease
$815,028Anton Iliuk · Tymora Analytical Operations, Llc · R44 · FY2024 · AG
PET Imaging of Synaptic Density in Alzheimers Disease
$814,985Richard E Carson · Yale University · R01 · FY2018 · AG
Longitudinal MRI Investigation of Traumatic Microvascular Injury
$814,905Jeffrey B Ware · University Of Pennsylvania · R01 · FY2022 · NS
CORE--CLINICAL
$814,900Charles Decarli · University Of California At Davis · P30 · FY2008 · AG
Validation of Fluorine-18 radioligand for PET imaging of synaptic density in Alzheimer's disease
$814,874Yiyun Henry Huang · Yale University · R01 · FY2020 · AG
Enhanced Quality in Primary Care for Elders with Diabetes and Dementia (EQUIPED-ADRD)
$814,850Caroline S Blaum · New York University School Of Medicine · R33 · FY2019 · AG
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$814,811Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2018 · NS
Molecular mechanism of bidirectional transport
$814,558William Olaf Hancock · Pennsylvania State University, The · R35 · FY2022 · GM
Longitudinal Blood-based Transcriptomic Changes in AD: Relation to Clinical and Biomarker Data
$814,533Andrew J Saykin · Mayo Clinic Jacksonville · U19 · FY2024 · AG
The Development of a High Throughput Whole Brain Alzheimer's Disease Drug Screening Pipeline
$814,482Timothy M. Ragan · Tissuevision, Inc. · R44 · FY2021 · AG
Alzheimer's Disease Neuroimaging Initiative
$814,442Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2012 · AG
Measuring metabolism of C-terminal fragments of amyloid beta in the human central
$814,440Tim West · C2n Diagnostics, Llc · R44 · FY2011 · AG
Building an unbiased pooled cohort for the study of lifecourse social and vascular determinants of Alzheimer's Disease and Related Disorders
$814,437Adina Zeki Al Hazzouri · Columbia University Health Sciences · R01 · FY2021 · AG
Design And Development Of Experimental Therapeutics
$814,403Nigel H. Greig · National Institute On Aging · ZIA · FY2009 · AG
Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat
$814,349Stephen N. Gomperts · Massachusetts General Hospital · R01 · FY2025 · AG
The role of sex in GABAergic-mediated, Alzheimerâs disease-related episodic memory impairments from mid to late life
$814,235Teal S Eich · University Of Southern California · R01 · FY2022 · AG
Early Cognitive Training and Rehabilitation to Prevent Cognitive Decline in Older Hospitalized Adults with Delirium
$814,217Jin Ho Han · Vanderbilt University Medical Center · R01 · FY2023 · AG
Vascular contributions to HIV-associated Neurocognitive Disorders (HAND)
$814,209Jose Gutierrez · Columbia University Health Sciences · R01 · FY2023 · AG